Hydrocodone: A New Recommendation And A New Drug

• Autores: Diane S. Aschenbrenner
• Localización: American Journal of Nursing, ISSN 0002-936X, Vol. 114, Nº. 2, 2014, págs. 24-25
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • * The Food and Drug Administration is recommending that drugs containing the narcotic hydrocodone be reclassified as schedule II controlled substances, indicating that they carry a higher potential for abuse than was previously believed.

    * The agency also recently approved an extended-release form of hydrocodone, Zohydro ER, as a single entity for the treatment of severe and chronic pain when other treatment options have been inadequate.

    * Like other extended-release and long-acting narcotics, Zohydro ER's labeling will carry strong warnings of its potential for abuse or overdose and its possible adverse effects.